Communiqués Kiniksa Pharmaceuticals, Ltd.

Actions

KNSA

BMG5269C1010

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
19,01 ^USD	+2,37 %		-0,21 %	+8,38 %

14/05	Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:40 AM
23/04	Kiniksa Pharmaceuticals aggrave sa perte au premier trimestre, mais ses revenus augmentent	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Analysts Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL)	28/05	AQ
Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference	07/05	AQ
Kiniksa Pharmaceuticals Reports First Quarter 2024 Financial Results and Recent Portfolio Execution	23/04	AQ
Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024	16/04	AQ
Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart	02/04	AQ
PRACTICE STATEMENT LETTER PROPOSED SCHEME OF ARRANGEMENT IN RESPECT OF: KINIKSA PHARMACEUTICALS, LTD - Form 8-K	29/03	PU
Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution	28/02	AQ
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024	21/02	AQ
Kiniksa Pharmaceuticals Provides Corporate Update	04/01	AQ
Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference	02/01	AQ
Kiniksa Pharmaceuticals Reports Third Quarter 2023 Financial Results and Recent Portfolio Execution	31/10/23	AQ
Kiniksa Pharmaceuticals to Report Third Quarter 2023 Financial Results on October 31, 2023	24/10/23	AQ
Kiniksa Pharmaceuticals Reports Second Quarter 2023 Financial Results and Recent Portfolio Execution	25/07/23	AQ
Kiniksa Pharmaceuticals to Report Second Quarter 2023 Financial Results on July 25, 2023	17/07/23	AQ
Kiniksa Pharmaceuticals : 2022 Annual Report	15/06/23	PU
Kiniksa Pharmaceuticals : 2023 Proxy Statement	15/06/23	PU
Kiniksa Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference	06/06/23	AQ
KINIKSA PHARMACEUTICALS, LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	04/05/23	AQ
Kiniksa Pharmaceuticals Reports First Quarter 2023 Financial Results and Recent Portfolio Execution	02/05/23	AQ
Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023	01/05/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Kiniksa Pharmaceuticals, Ltd.

Actions

KNSA

BMG5269C1010

Communiqués

Filtres